Facility Design and Engineering

Aug 10, 2018
By Pharmaceutical Technology Editors
The agency issued a warning letter to Canadian API manufacturer, Les Produits Chimiques B.G.R, citing cGMP violations at its API facility in Pointe-Claire, Quebec.
Aug 02, 2018
Pharmaceutical Technology
Modular manufacturing systems offer a less costly way to increase capacity while reducing time-to-market.
Aug 02, 2018
By Pharmaceutical Technology Editors
The company broke ground on its $200-million, 120,000-sq-ft biomanufacturing plant in West Greenwich, RI.
Aug 01, 2018
Pharmaceutical Technology
Why shouldn’t biopharmaceutical manufacturers be able to leverage standardized construction practices to improve time to market?
Aug 01, 2018
Pharmaceutical Technology
This article provides a sampling of the latest investments, expansions, and acquisitions by small-molecule contract service providers.
Aug 01, 2018
Pharmaceutical Technology
CMOs have been active over the past year in expanding their biologics production and capabilities.
Jul 19, 2018
By Pharmaceutical Technology Editors
The agency has issued a warning letter for cGMP violations at a drug manufacturing facility in Ahmedabad, India, that Baxter gained through its acquisition of Claris Injectables.
Jul 18, 2018
Equipment and Processing Report
Modern technologies, including Industry 4.0 and the Industrial Internet of Things, offer opportunities to increase biopharmaceutical manufacturing efficiency.
Jul 17, 2018
By Pharmaceutical Technology Editors
Moderna’s new manufacturing plant in Norwood, MA gives the company capacity for preclinical and Phase I and II clinical manufacturing for its mRNA development candidates, including personalized cancer vaccines.
Jul 10, 2018
By Pharmaceutical Technology Editors
The expansion at the company’s Gillingham, UK, site, worth EUR 9 million (approximately US$10.5 million), will improve the company’s distribution capabilities.
native1_300x100
lorem ipsum